Merck KGaA moves to block Schering acquisition

Merck KGaA is rapidly building up a 25 percent stake in Schering in order to block Bayer's €86 million takeover bid for the company, according to a report by AFX. Bayer's bid is conditional on a 75 percent acceptance rate by Wednesday. AFX reports that Merck KGaA is expected to announce it has acquired more than 25 percent of Schering's stock soon.

- read the AFX report for more

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.